Navigation Links
Dilon Diagnostics Gamma-Guided Localization System Cleared by FDA
Date:12/14/2009

GammaLMc® Helps Locate Breast Lesions Quickly and Accurately for Biopsy

Newport News, VA (Vocus) December 14, 2009 -- Dilon Diagnostics announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its lesion-localization system for molecular imaging biopsy guidance.

GammaLMc® is a complementary technology to Dilon’s cornerstone product, the Dilon 6800 Gamma Camera. The GammaLMc® (GL) system will help doctors accurately locate breast lesions and enable gamma-guided biopsies, particularly useful for patients that have findings on the Dilon system that are not revealed with other imaging modalities.

The GammaLMc® system utilizes a CorreLocator™ paddle and a StereoView™ imaging collimator system - a technique similar to that used in stereotactic X-ray localization, and the GammaLMc® software calculates the specific location of the suspect lesion. The compact design allows for breast biopsies with optimal patient comfort; and the entire system is small and portable, allowing physicians to perform molecular imaging guided biopsy procedures anywhere on site.

“Thanks to the superior performance of the Dilon 6800 camera combined with this new biopsy-guidance capability, physicians will find it easier to locate suspicious lesions seen with molecular breast imaging, greatly facilitating and expediting the biopsy process,” said Robert Moussa, President and CEO of Dilon Diagnostics. “This recent innovation helps physicians improve patient management and confidently deliver faster, more accurate results to their anxious patients.”

About Dilon Diagnostics:
Dilon Diagnostics, a brand of Dilon Technologies Inc. is bringing innovative new medical imaging products to market. Dilon’s cornerstone product, the Dilon 6800, is a high-resolution, small field-of-view gamma camera, optimized to perform BSGI, a molecular breast imaging procedure which images the metabolic activity of breast lesions through radiotracer uptake. Many leading medical centers around the country are now offering BSGI to their patients, including: Cornell University Medical Center, New York; George Washington University Medical Center, Washington, D.C.; and The Rose, Houston. For more information on Dilon Technologies please visit www.dilon.com.

###

Read the full story at http://www.prweb.com/releases/2009/12/prweb3341114.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Dilon Technologies Explores Improvements in Molecular Breast Imaging
2. Dilon Technologies Appoints New VP of Sales & Business Development
3. Settlement Reached Between Dilon Technologies and Naviscan on Patent Rights
4. Dilon Technologies Announces National Agreement with MedAssets
5. Dilon Technologies Signs Amerinet for Breast-Specific Gamma Imaging
6. Dilon Technologies Slant15(TM) and LEHR Collimators Enhance Imaging Capabilities
7. Dilon Technologies Leads Molecular Breast Imaging Expansion
8. Quest Diagnostics to Speak at the Bear Stearns Healthcare Conference
9. Pathway Diagnostics Announces Commercial Availability of SensiTrop(TM) HIV Co-receptor Tropism Assay
10. Hypertension Diagnostics Announces Fiscal Year 2007 Results
11. Foundation Venture Capital Group, LLC Invests in Start Up Committed to Breast Cancer Diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... Santa Rosa, California (PRWEB) , ... May 24, ... ... management (PHM) technology, debuted a new corporate identity and website at its “Transforming ... brand, website, and other marketing enhancements reflect i2i’s ongoing success to set the ...
(Date:5/24/2016)... ... May 24, 2016 , ... ... Center at Sentara Northern Virginia Medical Center located in Woodbridge, VA. The ... surgical services into a single site. , The new 2 story building houses ...
(Date:5/24/2016)... ... (PRWEB) May 24, 2016 -- Grow Healthy ... Advisory Board. Joining the Grow Healthy Advisory Board team are ... embody the mission of our organization and bring talent, expertise and ... as we continue to expand our footprint as the leader in ...
(Date:5/24/2016)... PA (PRWEB) , ... May 24, 2016 , ... A ... will rely heavily on their access to trusted resources, both in face-to-face interactions and ... Young Men of Color,” researchers concluded that the creative use of mobile digital devices ...
(Date:5/24/2016)... ... May 24, 2016 , ... ... increased by 9.3 million people, or 10% over last year, according to data ... covered under group policies was comparatively stable, with a slight decrease in risk-based ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... , May 23, 2016 ... Size, Share, Development, Growth and Demand Forecast to ... and Other), by Application (Drug Discovery and Development, ... Users (Pharmaceuticals, Life Science and Biotechnology, Academic and ... Market Research, the global mass spectrometry market ...
(Date:5/23/2016)... , May 23, 2016 Non-invasive ... detection of multiple diseases; ,Technology to be presented at ... Yissum Research Development Company of the Hebrew University ... a research agreement with Aurum Ventures MKI, the technology investment ... of a new diagnostic approach for early detection of ...
(Date:5/23/2016)... -- The global  reprocessed medical devices market ... according to a new study by Grand View Research, ... the lack of centralized support for waste disposal in ... for reprocessed medical devices market. Additionally, the long-term cost-efficiency ... the original device is the high impact rendering driver ...
Breaking Medicine Technology: